title: The conquest of 'river blindness'.
abstract: Studies carried out at the WHO/OCP Onchocerciasis Chemotherapeutic Centre in Tamale, Ghana, are reported, culminating in the clinical trials of ivermectin (Mectizan), which has revolutionized our approach to the treatment of the disease. It is concluded that the conquest of 'river blindness' is an eminently achievable goal.
authors.affiliation: Department of Pharmacology and Therapeutics, University of Liverpool, U.K.
authors.forename: H M
authors.initials: HM
authors.lastname: Gilles
authors.forename: K
authors.initials: K
authors.lastname: Awadzi
mesh_terms: D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D049673:History, 20th Century; D006801:Humans; D007559:Ivermectin / Q000009:adverse effects / Q000266:history / Q000627:therapeutic use*; D015827:Onchocerciasis, Ocular / Q000188:drug therapy* / Q000266:history
chemical_list: D007559:Ivermectin